176 related articles for article (PubMed ID: 4561201)
1. Tableting research and technology.
Cooper J; Rees JE
J Pharm Sci; 1972 Oct; 61(10):1511-55. PubMed ID: 4561201
[No Abstract] [Full Text] [Related]
2. Disintegration of tablets.
Lowenthal W
J Pharm Sci; 1972 Nov; 61(11):1695-711. PubMed ID: 4569113
[No Abstract] [Full Text] [Related]
3. Drug formulation and biologic availability.
Poole JW
Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
[No Abstract] [Full Text] [Related]
4. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
Tomassini L; Naplatanova D
Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
[No Abstract] [Full Text] [Related]
5. DEVELOPMENT OF COMPRESSED COATED POLYPILL WITH MUCOADHESIVE CORE COMPRISING OF ATORVASTATIN/CLOPIDOGREL/ASPIRIN USING COMPRESSION COATING TECHNIQUE.
Shahid N; Adnan S; Farooq M; Ali S; Shabbir M; Masood Z; Waqar K; Saleem H; Gill SA; Ali T
Acta Pol Pharm; 2017 Mar; 74(2):477-487. PubMed ID: 29624252
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical sciences--1968. A literature review of pharmaceutics.
Bernardo PD; Russo EJ
J Pharm Sci; 1969 Jul; 58(7):777-812. PubMed ID: 4898312
[No Abstract] [Full Text] [Related]
7. [Galenical possibilities and problems in protraction of drug effects (author's transl)].
Müller F
Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277
[TBL] [Abstract][Full Text] [Related]
8. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
9. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
Hänselmann B; Voigt R
Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
[No Abstract] [Full Text] [Related]
10. Mucoadhesive platforms for targeted delivery to the colon.
Varum FJ; Veiga F; Sousa JS; Basit AW
Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
[TBL] [Abstract][Full Text] [Related]
11. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances].
Hüttenrauch R; Schmeiss U
Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778
[No Abstract] [Full Text] [Related]
12. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
13. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
Schmid W; Picker-Freyer KM
Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the accuracy of different types of dissolution rate methods.
Bolhuis GK; Lerk CF; Zuurman K
Pharm Weekbl; 1973 Jan; 108(3):49-53. PubMed ID: 4699088
[No Abstract] [Full Text] [Related]
15. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.
Hombach J; Palmberger TF; Bernkop-Schnürch A
J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of drug absorption and of drug solution.
Jollow DJ; Brodie BB
Pharmacology; 1972; 8(1):21-32. PubMed ID: 4644653
[No Abstract] [Full Text] [Related]
18. Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology.
Ando M; Kojima S; Ozeki Y; Nakayama Y; Nabeshima T
Int J Pharm; 2007 May; 336(1):99-107. PubMed ID: 17223295
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro availability of commercial warfarin tablets.
Wagner JG; Welling PG; Lee KP; Walker JE
J Pharm Sci; 1971 May; 60(5):666-77. PubMed ID: 5125762
[No Abstract] [Full Text] [Related]
20. [Enteric coating].
Delporte JP
Pharm Acta Helv; 1970 Sep; 45(9):525-52. PubMed ID: 4918879
[No Abstract] [Full Text] [Related]
[Next] [New Search]
